PRATIVA BHANDARI: Open Payments
NPI 1619445210 · FULSHEAR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 82 payments from 14 companies in 2025. Trend: 2023 $929 · 2024 $1,368 · 2025 $1,535
Food & beverage: $1,526Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $349 |
| AstraZeneca Pharmaceuticals LP | 7 | $226 |
| Lilly USA, LLC | 13 | $210 |
| Novo Nordisk Inc | 11 | $197 |
| PFIZER INC. | 9 | $194 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Exact Sciences Corporation | 4 | $69 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
Products named: MOUNJARO, NURTEC ODT, QULIPTA, FARXIGA, VRAYLAR, Ozempic, Kerendia, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
